Abstract:Objective: To investigate the mid-term local treatment efficiency of ultrasound-guided percutaneous microwave ablation (MWA) for uterine fibroids (UFs) and the associated influencing factors. Methods: From July 2020 to October 2021, a total of 28 patients with 52 UFs who had undergone ultrasound-guided MWA were retrospectively included in this study. Pre-treatment clinical characteristics, conventional ultrasound and contrast-enhanced ultrasound (CEUS) features were analyzed to explore their correlation with volume reduction ratios (VRRs) of sufficient ablation (i.e. a VRR of at least 50% at the 3 month follow-up). The patients were assessed at 1-, 3-, 6 month follow-up after MWA treatment and the assessment included VRR, adverse events, uterine fibroid symptom (UFS) and quality of life (QoL) scores, and clinical symptoms. Results: The procedures of percutaneous MWA for UFs were tolerated well and no major complications occurred in all patients. At the 1-, 3-, 6 month follow-up, the median VRRs of UFs were 30.1%, 46.9%, and 65.8%, respectively. At the 3 month follow-up, 44.4% of fibroids obtained sufficient ablation while the remaining 55.6% obtained partial ablation (i.e. a VRR of <50%). Non-enhancing area during the early phase (i.e. within 30 s after injecting contrast agent) on pre-treatment CEUS was present in 22.2% UFs, which was associated with sufficient ablation at the 3 month follow-up (p < 0.05). In addition, the relevant clinical symptoms of all patients were alleviated or removed. The UFS and QoL score after MWA decreased significantly in comparison with those after MWA (p = 0.04 and p = 0.057, respectively), indicating a remarkable improvement of clinical symptom and QoL. Conclusion: Ultrasound-guided MWA is an effective and safe method to treat patients with UFs. Non-enhancing area during the early phase on pretreatment CEUS is associated with mid-term local treatment efficiency, which might be used to predict treatment outcome. Advances in knowledge: Non-enhancing area during the early phase on pretreatment CEUS is an important factor associated with mid-term local treatment efficiency. This is the first study finding that CEUS feature can be used as a marker for the prediction of mid-term local treatment response.

Volume Reduction for ≥2 Cm Benign Breast Lesions after Ultrasound-Guided Microwave Ablation with a Minimum 12-Month Follow-Up

Microwave Ablation (MWA) For≥ 2 Cm Benign Breast Lesions (Bbls)

Ultrasound-guided Percutaneous Microwave Ablation for 755 Benign Breast Lesions: a Prospective Multicenter Study

Ultrasound Guided Percutaneous Microwave Ablation of Benign Breast Lesions.

Microwave Ablation of Benign Breast Tumors: a Prospective Study with Minimum 12 Months Follow-Up.

Percutaneous Microwave Ablation Versus Breast Conserving Surgery for 2-5Cm Breast Cancer: A Two-Center, Retrospective Study

Therapeutic effect of ultrasound-guided percutaneous microwave ablation for benign breast lesions

Microwave Ablation of Benign Thyroid Nodules: 3-Year Follow-Up Outcomes

Microwave Ablation for Benign Thyroid Nodules with Cosmetic Problems and Related Factors for Post-Ablative Complete Relief: a Two-Center Retrospective Study

Learning Curve of Microwave Ablation for Liver Cancers

Is Partial Ablation Appropriate for Benign Thyroid Nodules? A Retrospective Study with Long-Term Follow-Up after Microwave Ablation

Mammotome® Biopsy System for the Resection of Breast Lesions: Clinical Experience in Two High-Volume Teaching Hospitals

Percutaneous Microwave Ablation: A Viable Local Therapy for Breast Cancer Involving the Skin/Nipple-Areola Complex?

Microwave ablation without subsequent lumpectomy versus breast-conserving surgery for early breast cancer: a propensity score matching study

Factors Related to Recurrence of the Benign Non-Functioning Thyroid Nodules after Percutaneous Microwave Ablation.

Dynamic Changes in Liver Volume Calculated Using a Three-Dimensional Visualisation System after Microwave Ablation of Hepatocellular Carcinomas.

Us-Guided Percutaneous Microwave Ablation of Renal Cell Carcinoma: Intermediate-Term Results

Preliminary study of ultrasound-guided percutaneous microwave ablation therapy for benign breast nodules

Ultrasound-guided Percutaneous Microwave Ablation for Uterine Fibroids: Mid-Term Local Treatment Efficiency and Associated Influencing Factors.

Ultrasound-guided percutaneous microwave ablation of sporadic renal angiomyolipoma: preliminary results.

Percutaneous Microwave Ablation for Liver Tumours Adjacent to the Marginal Angle.